Entegrion

Entegrion is a private, U.S.-based medical device company specializing in point-of-care viscoelastic testing for blood coagulation. Its flagship VCM system is CE-marked for human use in Europe and available as VCMVet for veterinary applications, but is not yet cleared for human clinical use in the United States. The company has a strong background in military medicine, having secured over $100 million in U.S. Department of Defense development contracts, and is led by a team with extensive experience in healthcare, emergency medicine, and neurology. Entegrion's strategy centers on transforming a complex laboratory test into an accessible bedside tool to guide critical decisions in trauma, surgery, and other acute care scenarios.

Viscoelastic Coagulation Monitor (VCM): A portable, automated, point-of-care diagnostic system that uses fresh whole blood to provide real-time, comprehensive assessment of hemostatic function (clot formation, strength, and dissolution).

Entegrion competes in the viscoelastic testing market against dominant players like Haemonetics (with the TEG system) and Werfen/Instrumentation Laboratory (with the ROTEM system). Its competitive differentiation is based on portability, full automation, and a true point-of-care design aimed at simplifying use and expanding testing locations.